Fabry and Stroke Epidemiological Protocol (FASEP): Risk Factors In Ischemic Stroke Patients With Fab Study Type: Observational Study Design: Observational Model: Cohort Time Perspective: Prospective Official Title: FASEP Fabry and Stroke Epidemiological Protocol RISK FACTORS IN ISCHEMIC STROKE PATIENTS WITH FABRY DISEASE AN ...
Fabry Disease Clinical Research Trials | CenterWatch Fabry Disease Clinical Research Trial Listings in Gastroenterology Pediatrics, Neonatology Genetic Disease Neurology on CenterWatch.
Fabry Disease Registry - Full Text View - ClinicalTrials.gov 2005年9月13日 - To enhance the understanding of the variability, progression, and natural history of Fabry disease, including heterozygous females with the ...
Dose-ranging Study of PRX-102 in Adult Fabry Disease ... 2012年8月31日 - Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients ... Genetic and Rare Diseases Information Center resources: Fabry Disease Sphingolipidosis ... from monitoring with clinical laboratory, physical examination and ECG ... Participa
Fabrazyme ® | Fabry Disease Information and History Fabry disease is a rare, inherited X-linked lysosomal storage disorder with multisystemic effects. ... Fabrazyme has been evaluated in several clinical trials.
First gene therapy trial launched for Fabry disease | News ... 2013年1月24日 - Now researchers in Calgary have launched the first gene therapy clinical trial in the world for Fabry disease that could ultimately lead to a ...
Canada launches first gene therapy trial for Fabry disease 2013年1月24日 - CALGARY – Researchers in Calgary have launched the first gene therapy clinical trial in the world for Fabry disease, a rare inherited enzyme ...
Enzyme replacement therapy for Fabry disease: proving the ... One of the most severely affected organs in Fabry disease is the kidney. ..... A phase I/II clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, ...
Fabry Disease Consortium - 臺灣臨床試驗合作聯盟 “Taiwan Clinical Trial Consortium in Fabry Disease” is established to solve the foregoing problems. The consortium is comprised of Confirmatory Diagnosis ...
ongoing clinical studies - Amicus Therapeutics Long-Term, Open-Label Study of Migalastat HCl (AT1001) in Subjects with Fabry Disease Who Completed Treatment in a Previous Monotherapy Trial with ...
